Praxis Precision Medicines (PRAX) Return on Sales (2023 - 2025)
Historic Return on Sales for Praxis Precision Medicines (PRAX) over the last 3 years, with Q3 2025 value amounting to 39.28%.
- Praxis Precision Medicines' Return on Sales rose 1489200.0% to 39.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 39.28%, marking a year-over-year increase of 629100.0%. This contributed to the annual value of 23.4% for FY2024, which is 282400.0% up from last year.
- Per Praxis Precision Medicines' latest filing, its Return on Sales stood at 39.28% for Q3 2025, which was up 1489200.0% from 34.98% recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Return on Sales ranged from a high of 8.57% in Q4 2024 and a low of 188.2% during Q3 2024
- Moreover, its 3-year median value for Return on Sales was 53.99% (2023), whereas its average is 64.63%.
- As far as peak fluctuations go, Praxis Precision Medicines' Return on Sales tumbled by -1336700bps in 2024, and later soared by 1489200bps in 2025.
- Praxis Precision Medicines' Return on Sales (Quarter) stood at 53.99% in 2023, then soared by 84bps to 8.57% in 2024, then crashed by -358bps to 39.28% in 2025.
- Its Return on Sales was 39.28% in Q3 2025, compared to 34.98% in Q2 2025 and 28.69% in Q1 2025.